However, against the backdrop of distinct metabolic reprogramming in breast cancer, such as increased glycolysis and subtype-specific metabolic traits, a critical knowledge gap remains regarding the mechanism by which these metabolic cues impinge on GSDM -mediated pyroptosis. The gene discussed is GSDMA; the disease is breast cancer.